Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943930 · ClinicalTrials.gov registry record
Marijuana Drug Discrimination and Self-Administration
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 29
- Enrollment target
NCT00943930: Completed study, sponsored by Wayne State University.
NCT00943930 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00943930 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study is designed to investigate the associations among marijuana's discriminative stimulus, reinforcing, subjective (e.g. craving) and physiological effects, and to assess the relative ability of oral THC to block these effects.
Primary Outcome
Three hours after each smoked marijuana dose the participant will complete the MCP-Q to make 15 independent choices between the drug dose sampled and various money amounts.
Interventions
- DRUG THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
What the finished NCT00943930 record still lists
NCT00943930 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC is the first listed.
NCT00943930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00943930 about?
NCT00943930 is a clinical study titled "Marijuana Drug Discrimination and Self-Administration". This study is designed to investigate the associations among marijuana's discriminative stimulus, reinforcing, subjective (e.g. craving) and physiological effects, and to assess the relative ability of oral THC to block these effects.
What is the current status of trial NCT00943930?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00943930?
The interventions under investigation include: THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC (DRUG).
Who is sponsoring clinical trial NCT00943930?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia